THE HAGUE, Netherlands, October 13, 2026 — Amber Implants, a medical technology company advancing minimally invasive solutions for vertebral reconstruction and targeted stabilization, today announced… Read More »Amber Implants Announces U.S. Introduction of VCFix® Spinal System
Study evaluates VCFix® used with or without bone cement, expanding clinical experience with the company’s minimally invasive spine platform. The Hague, Netherlands, June 17, 2026… Read More »Amber Implants Advances Pivotal European EXPAND Study of VCFix® Spinal System in Standalone Vertebral Reconstruction
We’re looking forward to attending the American Society of Spine Radiology (ASSR) 2026 Annual Meeting, February 26-28, in New Orleans, LA. As we expand into… Read More »EVENT: Amber Implants will attend the ASSR 2026 Annual Meeting in New Orleans, LA!
Amber Implants will attend the DWG Annual Meeting in Wiesbaden! We’re looking forward to attending the 20th Annual Meeting of the Deutsche Wirbelsäulengesellschaft (DWG) on… Read More »EVENT: Upcoming Friday Amber Implant will attend the German Spine Congress
Amber Implants is heading to the 40th North American Spine Society Annual Meeting, Nov 14–16 in Denver. Our CEO, Vincent Gardès, and CTO, Mo Ahmadi,… Read More »EVENT: Amber Implants will attend the NASS Annual Meeting in Denver
The Hague, The Netherlands, 6 November 2025 – Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announced the appointment… Read More »NEWS: Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive Commercial Launch of VCFix® Spinal System
We’re excited to take part in this year’s EuroSpine Annual Meeting (October 22–24) and to share new updates on VCFix combined with short-level posterior fixation… Read More »EVENT: Amber Implants will attend the Eurospine 2025 in Copenhagen
The Hague, The Netherlands, 17 September 2025 – Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announced it has… Read More »NEWS: Amber Implants Secures FDA 510(k) Clearance for VCFix® Spinal System: A Next-Generation Solution for Vertebral Compression Fractures
The Hague, The Netherlands, 3 June 2025 – Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announces the completion… Read More »NEWS: Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical of VCFix® Spinal System
The Hague, Netherlands, 11 June 2024: Amber Implants (‘Amber’ or ‘the Company’), an innovative medical technology company developing next-generation implants for spinal injuries, today announces… Read More »NEWS: Amber Implants Completes Enrolment of First-In-Human Clinical Trial of its VCFix® Spinal System
